1. Home
  2. DOLE vs EVO Comparison

DOLE vs EVO Comparison

Compare DOLE & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dole plc

DOLE

Dole plc

HOLD

Current Price

$15.24

Market Cap

1.2B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.02

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOLE
EVO
Founded
1851
1993
Country
Ireland
Germany
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DOLE
EVO
Price
$15.24
$3.02
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
936.7K
264.3K
Earning Date
11-10-2025
11-05-2025
Dividend Yield
2.23%
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$8,974,210,000.00
$887,396,457.00
Revenue This Year
$9.28
N/A
Revenue Next Year
$1.84
$8.80
P/E Ratio
$101.35
N/A
Revenue Growth
7.09
N/A
52 Week Low
$12.20
$2.84
52 Week High
$15.73
$5.10

Technical Indicators

Market Signals
Indicator
DOLE
EVO
Relative Strength Index (RSI) 62.65 42.59
Support Level $15.32 $2.87
Resistance Level $15.65 $3.05
Average True Range (ATR) 0.27 0.10
MACD -0.01 0.01
Stochastic Oscillator 57.32 35.14

Price Performance

Historical Comparison
DOLE
EVO

About DOLE Dole plc

Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: